FDA Drug recall D-0175-2021
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only
- FDA Drug
- Class III
- terminated
- Published 2021-01-06
On 2021-01-06 the FDA classified a Class III recall of Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only by Us Compounding, citing labelling: Missing label.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0175-2021 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-11-25 |
| Published | 2021-01-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Us Compounding |
| Distribution | US |
Product
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05
Reason
Labelling: Missing label.
Identifiers
| code_info | Lot: 20202109@3 BUD: 3/20/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0175-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.